Articles

Potential Alzheimer’s drug further backs protein hypothesis

The results of an experimental drug for Alzheimer’s disease provide the best evidence so far that the memory-robbing condition is caused by an errant protein in the brain. Drugmakers including Eli Lilly have been concentrating their Alzheimer’s research on that area.

Read More

Lilly joins $100M global Alzheimer’s venture fund

Major drugmakers—including Indianapolis-based Eli Lilly and Co.—the British government and a top Alzheimer's research charity are pooling more than $100 million to create a global fund to accelerate efforts to find a treatment or cure.

Read More

Can Hc1 become the Salesforce.com of health care?

Zionsville-based Hc1 is using its latest round of funding to expand from its roots—making software to help medical labs, pharmacies, physicians and hospital systems track the business relationships they have with one another—into a company that also helps those organizations interact directly with patients.

Read More

Senate panel considers ‘right-to-try’ trial drugs bill

An Indiana Senate committee is considering a bill that would give terminally ill patients easier access to experimental drugs that have not received full federal approval. Indiana is one of nearly two dozen states that are considering the legislation.

Read More

Debate on cold medicine prescriptions lingers

Lawmakers involved in the debate over how to curb Indiana's methamphetamine problem say a bill that would require drug felons to get a prescription before buying common cold medicine is likely just another step toward an eventual prescription requirement for all consumers.

Read More